Christophe Ribuot

Christophe Ribuot

Auto-generated profile, based on publicly available information

Christophe Ribuot

UJF, Laboratoire HP2, Grenoble F‐38000, France

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2008 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
PLPatrick LEVY
Patrick LEVY
JPJean-Louis Pepin
Jean-Louis Pepin
Claire ArnaudClaire Arnaud
Claire Arnaud
RTRenaud Tamisier
Renaud Tamisier
JBJ-C. Borel
J-C. Borel
CRC. Ribuot
C. Ribuot
There are three major types of sleep-disordered breathing (SDB) with respect to prevalence and health consequences,i.e.obstructive sleep apnoea syndrome (OSAS), Cheyne–Stokes respiration and central sleep apnoea (CSR-CSA) in chronic heart failure, and obesity hypoventilation syndrome (OHS). In all three conditions, hypoxia appears to affect body functioning in different ways. Most of the molecular and cellular mechanisms that occur in response to SDB-related hypoxia remain unknown.In OSAS, an inflammatory cascade mainly dependent upon intermittent hypoxia has been described. There is a strong interaction between haemodynamic and inflammatory changes in promoting vascular remodelling. Moreover, during OSAS, most organ, tissue or functional impairment is related to the severity of nocturnal hypoxia. CSR-CSA occurring during heart failure is primarily a consequence of cardiac impairment. CSR-CSA has deleterious consequences for cardiac prognosis and mortality since it favours sympathetic activation, ventricular ectopy and atrial fibrillation. Although correction of CSR-CSA seems to be critical, there is a need to establish therapy guidelines in large randomised controlled trials.Finally, OHS is a growing health concern, owing to the worldwide obesity epidemic and OHS morbidities. The pathophysiology of OHS remains largely unknown. However, resistance to leptin, obesity and severe nocturnal hypoxia lead to insulin resistance and endothelial dysfunction. In addition, several adipokines may be triggered by hypoxia and explain, at least in part, OHS morbidity and mortality.Overall, chronic intermittent hypoxia appears to have specific genomic effects that differ notably from continuous hypoxia. Further research is required to fully elucidate the molecular and cellular mechanisms.

1 April 2009 in JACC
Verified
Journal Article
Closed access
EBElise Belaidi
Elise Belaidi
MJMarie Joyeux-Faure
Marie Joyeux-Faure
CRChristophe Ribuot
Christophe Ribuot
SLSandrine H. Launois
Sandrine H. Launois
PLPatrick LEVY
Patrick LEVY
DGDiane Godin-Ribuot
Diane Godin-Ribuot

1 January 2009 in ILAR Journal
Verified
Journal Article
Open access
PDF file
MDMaurice Dematteis
Maurice Dematteis
DGDiane Godin-Ribuot
Diane Godin-Ribuot
Claire ArnaudClaire Arnaud
Claire Arnaud
CRChristophe Ribuot
Christophe Ribuot
FSFrançoise Stanke-Labesque
Françoise Stanke-Labesque
PLPatrick LEVY
Patrick LEVY
Sleep-disordered breathing, and particularly the highly prevalent obstructive sleep apnea syndrome, is a multicomponent disorder combining intermittent hypoxia (IH), sleep fragmentation, and obstructed respiratory efforts. It is frequently associated with comorbidities and leads to numerous complications, including cardiovascular consequences that are conditioned by genetic predisposition and environment. The complexity of the disease and the reduced possibilities for patient investigations, especially at the tissue level, have limited progress in the understanding of sleep apnea pathophysiology and in the development of specific treatments. Animal models make it possible to study the causative mechanisms (essentially upper airway dysfunction) and the consequences (cardiovascular, metabolic, and neurological alterations) of nocturnal respiratory events without the confounding factors that occur in humans. Such studies have revealed some of the pathophysiological mechanisms and enabled the recognition of IH as the most important sleep apnea component underlying cardiovascular complications. We review different animal models used to assess detrimental sleep apnea–related cardiovascular consequences: blood pressure elevation, impaired vasoreactivity, structural arterial remodeling leading to atherosclerosis, cardiac remodeling, and myocardial infarction. We also review experimental evidence of beneficial effects of IH. By combining clinical and experimental research, these models will contribute to the understanding of differential patient susceptibility and to the elaboration of prevention strategies and tailored treatments for sleep apnea patients.

15 September 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
Claire ArnaudClaire Arnaud
Claire Arnaud
PBPauline C. Beguin
Pauline C. Beguin
SLSylvie Lantuejoul
Sylvie Lantuejoul
JPJean-Louis Pepin
Jean-Louis Pepin
CGChristiane Guillermet
Christiane Guillermet
MDMaurice Dematteis
Maurice Dematteis
Rationale: The highly prevalent obstructive sleep apnea syndrome (OSA) with its main component intermittent hypoxia (IH) is a risk factor for cardiovascular mortality. The poor knowledge of its pathophysiology has limited the development of specific treatments, whereas the gold standard treatment, continuous positive airway pressure, may not fully reverse the chronic consequences of OSA and has limited acceptance in some patients. Objectives: To examine the contribution of IH-induced inflammation to the cardiovascular complications of OSA. Methods: We investigated systemic and vascular inflammatory changes in C57BL6 mice exposed to IH (21–5% FiO2, 60-s cycle) or normoxia 8 hours per day up to 14 days. Vascular alterations were reassessed in mice treated with a blocking antibody of regulated upon activation, normal T-cell expressed and secreted (RANTES)/CC chemokine ligand 5 (CCL5) signaling pathway, or with the IgG isotype control throughout the IH exposure. Measurements and Main Results: IH induced systemic inflammation combining increased splenic lymphocyte proliferation and chemokine expression, with early and predominant RANTES/CCL5 alterations, and enhanced splenocyte migration toward RANTES/CCL5. IH also induced structural and inflammatory vascular alterations. Leukocyte–endothelium adhesive interactions were increased, attested by leukocyte rolling and intercellular adhesion molecule-1 expression in mesenteric vessels. Aortas had increased intima–media thickness with elastic fiber alterations, mucoid depositions, nuclear factor-κB–p50 and intercellular adhesion molecule-1 overexpression, hypertrophy of smooth-muscle cells overexpressing RANTES/CCL5, and adventitial–periadventitial T-lymphocyte infiltration. RANTES/CCL5 neutralization prevented both intima–media thickening and inflammatory alterations, independently of the IH-associated proatherogenic dyslipidemia. Conclusions: Inflammation is a determinant mechanism for IH-induced preatherosclerotic remodeling involving RANTES/CCL5, a key chemokine in atherogenesis. Characterization of the inflammatory response could allow identifying at-risk patients for complications, and its pharmacologic manipulation may represent a potential complementary treatment of sleep apnea consequences.

7 December 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ARAmandine Ramond
Amandine Ramond
DGDiane Godin‐Ribuot
Diane Godin‐Ribuot
CRChristophe Ribuot
Christophe Ribuot
PTPerle Totoson
Perle Totoson
IKIrina Koritchneva
Irina Koritchneva
MJMarie Joyeux‐Faure
Marie Joyeux‐Faure

1 May 2005 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
MJM. Joyeux-Faure
M. Joyeux-Faure
FSF. Stanke-Labesque
F. Stanke-Labesque
BLB. Lefebvre
B. Lefebvre
PBP. Béguin
P. Béguin
DGD. Godin-Ribuot
D. Godin-Ribuot
PLPatrick LEVY
Patrick LEVY
Coronary heart disease is frequently associated with obstructive sleep apnea syndrome and treating obstructive sleep apnea appears to significantly improve the outcome in coronary heart disease. Thus we have developed a rat model of chronic intermittent hypoxia (IH) to study the influence of this condition on myocardial ischemia-reperfusion tolerance and on functional vascular reactivity. Wistar male rats were divided in three experimental groups ( n = 12 each) subjected to chronic IH (IH group), normoxia (N group), or control conditions (control group). IH consisted of repetitive cycles of 1 min (40 s with inspired O2fraction 5% followed by 20 s normoxia) and was applied for 8 h during daytime, for 35 days. Normoxic cycles were applied in the same conditions, inspired O2fraction remaining constant at 21%. On day 36, mean arterial blood pressure (MABP) was measured before isolated hearts were submitted to an ischemia-reperfusion protocol. The thoracic aorta and left carotid artery were also excised for functional reactivity studies. MABP was not significantly different between the three experimental groups. Infarct sizes (in percent of ventricles) were significantly higher in IH group (46.9 ± 3.6%) compared with N (26.1 ± 2.8%) and control (21.7 ± 2.1%) groups. Vascular smooth muscle function was similar in aorta and carotid arteries from all groups. The endothelium-dependent relaxation in response to acetylcholine was also similar in aorta and carotid arteries from all groups. Chronic IH increased heart sensitivity to infarction, independently of a significant increase in MABP, and did not affect vascular reactivity of aorta and carotid arteries.